|
|
Article: Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger.
- Article from:
- Vaccine Weekly
- Article date:
- July 8, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Merck & Co., Inc. (NYSE: MRK) and Schering-Plough Corporation (NYSE: SGP) announced that they each have received a request for additional information from the U.S. Federal Trade Commission (FTC) with respect to their previously announced proposed merger. The request for information from the FTC, often referred to as a "second request," was anticipated as part of the regulatory process under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) (see also Merck & Co., Inc.).
Merck and Schering-Plough intend to cooperate fully with the FTC to obtain approval of the transaction as expeditiously as possible. The transaction is subject to approval by ...